Cirugía y Especialidades Médico-Quirúrgicas
Departamento
Centro de Investigación Biomédica en Red sobre Bioingeniería, Biomateriales y Nanomedicina
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Bioingeniería, Biomateriales y Nanomedicina (17)
2023
-
Complications related to the Cook–Swartz implantable Doppler probe use in head and neck microvascular reconstruction: a systematic review
European Archives of Oto-Rhino-Laryngology, Vol. 280, Núm. 1, pp. 23-37
2022
-
Human Stem Cell Transplantation for Retinal Degenerative Diseases: Where Are We Now?
Medicina (Lithuania), Vol. 58, Núm. 1
2021
-
Use of autologous plasma rich in growth factors fibrin membrane in the surgical management of ocular surface diseases
International Ophthalmology, Vol. 41, Núm. 7, pp. 2347-2358
2020
-
Potential Effect of Plasma Rich in Growth Factors-Endoret in Stromal Wound Healing in Additive Surgery
Ophthalmic Research, Vol. 63, Núm. 2, pp. 203-212
2019
-
Role of corneal nerves in ocular surface homeostasis and disease
Acta Ophthalmologica, Vol. 97, Núm. 2, pp. 137-145
2018
-
Controlled Adverse Environment Chambers in Dry Eye Research
Current Eye Research, Vol. 43, Núm. 4, pp. 445-450
-
Differential profile of protein expression on human keratocytes treated with autologous serum and plasma rich in growth factors (PRGF)
PLoS ONE, Vol. 13, Núm. 10
-
Distinctive expression and amplification of genes at 11q13 in relation to HPV status with impact on survival in head and neck cancer patients
Journal of Clinical Medicine, Vol. 7, Núm. 12
-
Plasma rich in growth factors eye drops to treat secondary ocular surface disorders in patients with glaucoma
International Medical Case Reports Journal, Vol. 11, pp. 97-103
-
Plasma rich in growth factors for the treatment of dry eye after LASIK surgery
Ophthalmic Research, Vol. 60, Núm. 2, pp. 80-86
-
Plasma rich in growth factors membrane as coadjuvant treatment in the surgery of ocular surface disorders
Medicine (United States), Vol. 97, Núm. 17
-
Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops
International Ophthalmology, Vol. 38, Núm. 3, pp. 1193-1204
2017
-
Allogeneic blood-based therapies: Hype or hope?
Eye (Basingstoke)
-
Autologous method for ex vivo expansion of human limbal epithelial progenitor cells based on plasma rich in growth factors technology
Ocular Surface, Vol. 15, Núm. 2, pp. 248-256
-
Regenerative therapies in dry eye disease: From growth factors to cell therapy
International Journal of Molecular Sciences, Vol. 18, Núm. 11
-
The Effect of Immunologically Safe Plasma Rich in Growth Factor Eye Drops in Patients with Sjögren Syndrome
Journal of Ocular Pharmacology and Therapeutics, Vol. 33, Núm. 5, pp. 391-399
2016
-
PRGF exerts more potent proliferative and anti-inflammatory effects than autologous serum on a cell culture inflammatory model
Experimental Eye Research, Vol. 151, pp. 115-121